InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,446.37
(
0.27%
)
US TECH 100
19,237.60
(
0.37%
)
Dow Jones
38,609.66
(
0.05%
)
Brent Oil
83.14
(
1.24%
)
Bitcoin
65,257.49
(
-2.08%
)
Post# of 461483
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

shortridge3w

Send PM Follow Ignore
Followers 1
Posts 164
Boards Moderated 0
Alias Born 07/22/2016

shortridge3w

Re: None

Wednesday, 12/28/2016 7:15:53 AM

Wednesday, December 28, 2016 7:15:53 AM

Post# of 461483
The following comes from AVXL website:

Human clinical trials

Anavex completed a Phase 2a trial with ANAVEX 2-73 in November 2016.

Thereafter, the Company plans to initiate a potentially pivotal 6/12-month Phase 2/3 trial with ANAVEX 2-73. This trial is expected to include up to 300 mild-to-moderate Alzheimer’s patients.

Clinical trials are conducted by third-party organizations, not by Anavex directly. Trial participants are selected independently of the company to avoid undue influence.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Start posting your company's news
Only $200 per official company press release!